Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.
2.

Opioid Prescriptions at Hospital Discharge Are Associated With More Postdischarge Healthcare Utilization.

Liberman JS, Samuels LR, Goggins K, Kripalani S, Roumie CL; VICS (Vanderbilt Inpatient Cohort Study).

J Am Heart Assoc. 2019 Feb 5;8(3):e010664. doi: 10.1161/JAHA.118.010664.

3.

The impact of the WHO Framework Convention on Tobacco Control in defending legal challenges to tobacco control measures.

Zhou SY, Liberman JD, Ricafort E.

Tob Control. 2019 Jun;28(Suppl 2):s113-s118. doi: 10.1136/tobaccocontrol-2018-054329. Epub 2018 Jun 2.

4.

FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity.

Ettinger RA, Liberman JA, Gunasekera D, Puranik K, James EA, Thompson AR, Pratt KP.

Blood Adv. 2018 Feb 27;2(4):309-322. doi: 10.1182/bloodadvances.2017013482.

5.

Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™.

Vescovo P, Rettby N, Ramaniraka N, Liberman J, Hart K, Cachemaille A, Piveteau LD, Zanoni R, Bart PA, Pantaleo G.

Vaccine. 2017 Mar 27;35(14):1782-1788. doi: 10.1016/j.vaccine.2016.09.069.

6.

E-Cigarettes-What a Practicing Cardiologist Needs to Know.

Liberman J, Wann S.

Am J Cardiol. 2017 Feb 15;119(4):681-686. doi: 10.1016/j.amjcard.2016.11.011. Epub 2016 Nov 19.

PMID:
28017304
7.

Difficult Ventilation After Successful Intubation in the Emergency Setting due to a Ball Valve Clot.

Liberman JS, Weigel W, Neal JM.

A A Case Rep. 2016 May 15;6(10):291-2. doi: 10.1213/XAA.0000000000000294.

PMID:
26934604
8.

Global cancer surgery: delivering safe, affordable, and timely cancer surgery.

Sullivan R, Alatise OI, Anderson BO, Audisio R, Autier P, Aggarwal A, Balch C, Brennan MF, Dare A, D'Cruz A, Eggermont AM, Fleming K, Gueye SM, Hagander L, Herrera CA, Holmer H, Ilbawi AM, Jarnheimer A, Ji JF, Kingham TP, Liberman J, Leather AJ, Meara JG, Mukhopadhyay S, Murthy SS, Omar S, Parham GP, Pramesh CS, Riviello R, Rodin D, Santini L, Shrikhande SV, Shrime M, Thomas R, Tsunoda AT, van de Velde C, Veronesi U, Vijaykumar DK, Watters D, Wang S, Wu YL, Zeiton M, Purushotham A.

Lancet Oncol. 2015 Sep;16(11):1193-224. doi: 10.1016/S1470-2045(15)00223-5. Review.

PMID:
26427363
9.

Dental caries in Uruguayan adults and elders: findings from the first Uruguayan National Oral Health Survey.

Álvarez L, Liberman J, Abreu S, Mangarelli C, Correa MB, Demarco FF, Lorenzo S, Nascimento GG.

Cad Saude Publica. 2015 Aug;31(8):1663-72. doi: 10.1590/0102-311X00132214.

10.

Molecular mechanism for preQ1-II riboswitch function revealed by molecular dynamics.

Aytenfisu AH, Liberman JA, Wedekind JE, Mathews DH.

RNA. 2015 Nov;21(11):1898-907. doi: 10.1261/rna.051367.115. Epub 2015 Sep 14.

11.

Structural analysis of a class III preQ1 riboswitch reveals an aptamer distant from a ribosome-binding site regulated by fast dynamics.

Liberman JA, Suddala KC, Aytenfisu A, Chan D, Belashov IA, Salim M, Mathews DH, Spitale RC, Walter NG, Wedekind JE.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3485-94. doi: 10.1073/pnas.1503955112. Epub 2015 Jun 23.

12.

The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.

Mühlethaler-Mottet A, Liberman J, Ascenção K, Flahaut M, Balmas Bourloud K, Yan P, Jauquier N, Gross N, Joseph JM.

PLoS One. 2015 May 8;10(5):e0125616. doi: 10.1371/journal.pone.0125616. eCollection 2015.

13.

ITC analysis of ligand binding to preQ₁ riboswitches.

Liberman JA, Bogue JT, Jenkins JL, Salim M, Wedekind JE.

Methods Enzymol. 2014;549:435-50. doi: 10.1016/B978-0-12-801122-5.00018-0.

14.

Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study).

McAdam-Marx C, Bellows BK, Unni S, Mukherjee J, Wygant G, Iloeje U, Liberman JN, Ye X, Bloom FJ, Brixner DI.

Int J Clin Pract. 2014 Nov;68(11):1309-17. doi: 10.1111/ijcp.12502. Epub 2014 Aug 12.

15.

Fatal bleeding due to acquired factor IX and X deficiency: a rare complication of primary amyloidosis; case report and review of the literature.

Ericson S, Shah N, Liberman J, Aboulafia DM.

Clin Lymphoma Myeloma Leuk. 2014 Jun;14(3):e81-6. doi: 10.1016/j.clml.2013.08.007. Epub 2013 Nov 27. Review. No abstract available.

PMID:
24290671
16.

Single transcriptional and translational preQ1 riboswitches adopt similar pre-folded ensembles that follow distinct folding pathways into the same ligand-bound structure.

Suddala KC, Rinaldi AJ, Feng J, Mustoe AM, Eichhorn CD, Liberman JA, Wedekind JE, Al-Hashimi HM, Brooks CL 3rd, Walter NG.

Nucleic Acids Res. 2013 Dec;41(22):10462-75. doi: 10.1093/nar/gkt798. Epub 2013 Sep 3.

17.

Effect of an educational outreach program on prescribing potential drug-drug interactions.

Malone DC, Liberman JN, Sun D.

J Manag Care Pharm. 2013 Sep;19(7):549-57.

18.

Plainly constitutional: the upholding of plain tobacco packaging by the High Court of Australia.

Liberman J.

Am J Law Med. 2013;39(2-3):361-81. No abstract available.

PMID:
23815036
19.

Tracking the relevance of the WHO Framework Convention on Tobacco Control in legislation and litigation through the online resource, Tobacco Control Laws.

Muggli ME, Zheng A, Liberman J, Coxon N, Candler L, Donley K, Lambert P.

Tob Control. 2014 Sep;23(5):457-60. doi: 10.1136/tobaccocontrol-2012-050854. Epub 2013 May 4.

PMID:
23644394
20.

Structure of a class II preQ1 riboswitch reveals ligand recognition by a new fold.

Liberman JA, Salim M, Krucinska J, Wedekind JE.

Nat Chem Biol. 2013 Jun;9(6):353-5. doi: 10.1038/nchembio.1231. Epub 2013 Apr 14.

21.

Adherence to varenicline and associated smoking cessation in a community-based patient setting.

Liberman JN, Lichtenfeld MJ, Galaznik A, Mastey V, Harnett J, Zou KH, Leader JB, Kirchner HL.

J Manag Care Pharm. 2013 Mar;19(2):125-31.

22.

Alternative legal strategies for alcohol control: not a framework convention--at least not right now.

Liberman J.

Addiction. 2013 Mar;108(3):459-60. doi: 10.1111/j.1360-0443.2012.04065.x. No abstract available.

PMID:
23418653
23.

Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.

Hogerzeil HV, Liberman J, Wirtz VJ, Kishore SP, Selvaraj S, Kiddell-Monroe R, Mwangi-Powell FN, von Schoen-Angerer T; Lancet NCD Action Group.

Lancet. 2013 Feb 23;381(9867):680-9. doi: 10.1016/S0140-6736(12)62128-X. Epub 2013 Feb 12. Review.

PMID:
23410612
24.

A transition-state interaction shifts nucleobase ionization toward neutrality to facilitate small ribozyme catalysis.

Liberman JA, Guo M, Jenkins JL, Krucinska J, Chen Y, Carey PR, Wedekind JE.

J Am Chem Soc. 2012 Oct 17;134(41):16933-6. doi: 10.1021/ja3070528. Epub 2012 Oct 3.

25.

Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.

Liberman J, Sartelet H, Flahaut M, Mühlethaler-Mottet A, Coulon A, Nyalendo C, Vassal G, Joseph JM, Gross N.

PLoS One. 2012;7(8):e43665. doi: 10.1371/journal.pone.0043665. Epub 2012 Aug 20.

26.

Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.

Liberman J.

J Law Med Ethics. 2012 Summer;40(2):326-47. doi: 10.1111/j.1748-720X.2012.00667.x.

PMID:
22789049
27.

Targeting cardiovascular medication adherence interventions.

Cutrona SL, Choudhry NK, Fischer MA, Servi AD, Stedman M, Liberman JN, Brennan TA, Shrank WH.

J Am Pharm Assoc (2003). 2012 May-Jun;52(3):381-97. doi: 10.1331/JAPhA.2012.10211. Review.

PMID:
22618980
28.

Warnings without guidance: patient responses to an FDA warning about ezetimibe.

Shrank WH, Choudhry NK, Tong A, Myers J, Fischer MA, Swanton K, Slezak J, Brennan TA, Liberman JN, Moffit S, Avorn J, Carpenter D.

Med Care. 2012 Jun;50(6):479-84. doi: 10.1097/MLR.0b013e31825517b6.

PMID:
22581012
29.

Reducing long-term cost by transforming primary care: evidence from Geisinger's medical home model.

Maeng DD, Graham J, Graf TR, Liberman JN, Dermes NB, Tomcavage J, Davis DE, Bloom FJ, Steele GD Jr.

Am J Manag Care. 2012 Mar;18(3):149-55.

PMID:
22435908
30.
31.

Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.

Desai NR, Shrank WH, Fischer MA, Avorn J, Liberman JN, Schneeweiss S, Pakes J, Brennan TA, Choudhry NK.

Am J Med. 2012 Mar;125(3):302.e1-7. doi: 10.1016/j.amjmed.2011.07.033.

32.

Crystallographic analysis of small ribozymes and riboswitches.

Lippa GM, Liberman JA, Jenkins JL, Krucinska J, Salim M, Wedekind JE.

Methods Mol Biol. 2012;848:159-84. doi: 10.1007/978-1-61779-545-9_11.

33.

Implications of international law for the treatment of cancer: the Single Convention on Narcotic Drugs and the TRIPS Agreement.

Liberman J.

Public Health. 2011 Dec;125(12):840-846. doi: 10.1016/j.puhe.2011.09.032. Epub 2011 Nov 4.

PMID:
22054908
34.

Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.

Coulon A, Flahaut M, Mühlethaler-Mottet A, Meier R, Liberman J, Balmas-Bourloud K, Nardou K, Yan P, Tercier S, Joseph JM, Sommer L, Gross N.

Neoplasia. 2011 Oct;13(10):991-1004.

35.

Trouble getting started: predictors of primary medication nonadherence.

Fischer MA, Choudhry NK, Brill G, Avorn J, Schneeweiss S, Hutchins D, Liberman JN, Brennan TA, Shrank WH.

Am J Med. 2011 Nov;124(11):1081.e9-22. doi: 10.1016/j.amjmed.2011.05.028.

PMID:
22017787
36.

Riboswitch structure in the ligand-free state.

Liberman JA, Wedekind JE.

Wiley Interdiscip Rev RNA. 2012 May-Jun;3(3):369-84. doi: 10.1002/wrna.114. Epub 2011 Sep 28. Review.

37.

Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.

Polinski JM, Shrank WH, Huskamp HA, Glynn RJ, Liberman JN, Schneeweiss S.

PLoS Med. 2011 Aug;8(8):e1001075. doi: 10.1371/journal.pmed.1001075. Epub 2011 Aug 16. Erratum in: PLoS Med. 2014 Aug;11(8):e1001716.

38.

Opportunities and risks of the proposed FCTC protocol on illicit trade.

Liberman J, Blecher E, Carbajales AR, Burke F.

Tob Control. 2011 Nov;20(6):436-8. doi: 10.1136/tobaccocontrol-2011-050122. Epub 2011 Aug 5.

PMID:
21821819
39.

Adherence to medication under mandatory and voluntary mail benefit designs.

Liberman JN, Hutchins DS, Shrank WH, Slezak J, Brennan TA.

Am J Manag Care. 2011 Jul 1;17(7):e260-9.

40.

The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money.

Shrank WH, Choudhry NK, Liberman JN, Brennan TA.

Health Aff (Millwood). 2011 Jul;30(7):1351-7. doi: 10.1377/hlthaff.2010.0431. Review.

PMID:
21734210
41.

Are caregivers adherent to their own medications?

Shrank WH, Liberman JN, Fischer MA, Kilabuk E, Girdish C, Cutrona S, Brennan T, Choudhry NK.

J Am Pharm Assoc (2003). 2011 Jul-Aug;51(4):492-8. doi: 10.1331/JAPhA.2011.10006.

PMID:
21602166
42.

The implications of therapeutic complexity on adherence to cardiovascular medications.

Choudhry NK, Fischer MA, Avorn J, Liberman JN, Schneeweiss S, Pakes J, Brennan TA, Shrank WH.

Arch Intern Med. 2011 May 9;171(9):814-22.

PMID:
21555659
43.

Base ionization and ligand binding: how small ribozymes and riboswitches gain a foothold in a protein world.

Liberman JA, Wedekind JE.

Curr Opin Struct Biol. 2011 Jun;21(3):327-34. doi: 10.1016/j.sbi.2011.03.016. Epub 2011 Apr 27. Review.

44.

The consequences of requesting "dispense as written".

Shrank WH, Liberman JN, Fischer MA, Avorn J, Kilabuk E, Chang A, Kesselheim AS, Brennan TA, Choudhry NK.

Am J Med. 2011 Apr;124(4):309-17. doi: 10.1016/j.amjmed.2010.11.020.

PMID:
21435421
45.

Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis.

Mühlethaler-Mottet A, Flahaut M, Bourloud KB, Nardou K, Coulon A, Liberman J, Thome M, Gross N.

Cell Death Dis. 2011 Mar 3;2:e125. doi: 10.1038/cddis.2011.8.

47.

Modes of delivery for interventions to improve cardiovascular medication adherence.

Cutrona SL, Choudhry NK, Fischer MA, Servi A, Liberman JN, Brennan TA, Shrank WH.

Am J Manag Care. 2010;16(12):929-42. Review.

48.

Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence.

Misono AS, Cutrona SL, Choudhry NK, Fischer MA, Stedman MR, Liberman JN, Brennan TA, Jain SH, Shrank WH.

Am J Manag Care. 2010 Dec;16(12 Suppl HIT):SP82-92. Review.

49.

T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site.

James EA, van Haren SD, Ettinger RA, Fijnvandraat K, Liberman JA, Kwok WW, Voorberg J, Pratt KP.

J Thromb Haemost. 2011 Apr;9(4):689-99. doi: 10.1111/j.1538-7836.2011.04202.x.

50.

Revealed preference for community and mail service pharmacy.

Liberman JN, Wang Y, Hutchins DS, Slezak J, Shrank WH.

J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):50-7. doi: 10.1331/JAPhA.2011.09161.

PMID:
21247826

Supplemental Content

Loading ...
Support Center